Bio-Techne Corp at Jefferies Healthcare Conference Transcript
Okay. We'll go ahead and get started. Thanks, everybody, for being here. Good morning. Welcome to the Jefferies 2022 Global Healthcare Conference back in person. It's great to see everybody. I'm Brandon Couillard, I cover the life science tools and diagnostics space. Very happy to have Bio-Techne with us back at the conference this year. And here to share an update with us, CEO, Chuck Kummeth. Chuck?
Thank you. Is this working? Can you hear me? Good.
All right. Well, we'll get this started. It's been a while since we have given a presentation actually, so it's good to be back.
All right, good. First, our safe harbor. You guys have all seen these before, but we recommend you go online and look at our reconciliations and see all the real data.
Overview of our company. We're about a $15 billion company as of January to now. Like everybody else, we've come down a fair amount, but not as much as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
